Clinical Trials in Baltimore

Showing 8061-8080 of 17,842 trials

Association of Mood With Risk for Atherosclerosis

NCT04298944

The investigators will aim to determine the association of mood disorders (MDO) with preclinical and clinical cardiovascular (CVD) risk factors among children. The investigators will also aim to identify traditional and non traditional predictors of CVD risk among children with MDO.

Mood DisordersHypertensionOverweight and Obesity+3 more

Johns Hopkins University37 participantsStarted Mar 2020

Baltimore, Maryland, United States

TERMINATEDPhase 1/2< 1 mile

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

NCT02601209

This phase I/II trial studies the side effects and best dose of sapanisertib and to see how well it works compared to pazopanib hydrochloride in treating patients with sarcoma that is too large to be removed (locally advanced) or has spread to other areas of the body (metastatic). Sapanisertib and pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor+16 more

National Cancer Institute (NCI)151 participantsStarted Nov 2015

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +457 more locations

Association of Mood With Risk for Atherosclerosis

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Find Trials by Condition in Baltimore

3T MRI CIED Post-Approval Study

Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device

Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

The Long-Term Treatment of Drug Addiction and Unemployment

ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Genomic Translation for Amyotrophic Lateral Sclerosis Care

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients